Journal article icon

Journal article

Treating sleep problems in young people at ultra-high-risk of psychosis: study protocol for a single-blind parallel group randomised controlled feasibility trial (SleepWell)

Abstract:

Background: Effective interventions, targeting key contributory causal factors, are needed to prevent the emergence of severe mental health problems in young people. Insomnia is a common clinical issue that is problematic in its own right but that also leads to the development and persistence of psychotic experiences. The implication is that treating sleep problems may prevent the onset of psychosis. We collected initial case series data with 12 young people at ultra-high-risk of psychosis. Post-intervention, there were improvements in sleep, depression, and psychotic experiences. Now we test the feasibility of a randomised controlled trial, with a clinical aim to treat sleep problems and hence reduce depression, psychotic experiences, and prevent transition to psychosis.

Methods and analysis: A randomised controlled feasibility trial will be conducted. Forty patients aged 14-25 years who are at ultra-high-risk of psychosis and have sleep disturbance will be recruited from NHS mental health services. Participants will be randomised to receive either a novel, targeted, youth-focused sleep intervention in addition to usual care or usual care alone. Assessor-blinded assessments will be conducted at baseline, three months (post-intervention) and nine months (follow-up). The eight-session psychological intervention will target the key mechanisms which disrupt sleep: circadian rhythm irregularities, low sleep pressure, and hyperarousal. To gain an in-depth understanding of participants’ views on the acceptability of the intervention and study procedures, 16 participants (n=10 intervention, n=6 control) will take part in qualitative interviews. Analyses will focus on feasibility outcomes (recruitment, retention, and treatment uptake rates) and provide initial confidence interval estimates of intervention effects. Thematic analysis of the qualitative interviews will assess the acceptability of the intervention and trial procedures.

Ethics and dissemination: The trial has received ethical approval from the NHS Health Research Authority. Findings will be disseminated through peer-reviewed publications, conference presentations, and lay networks.

Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1136/bmjopen-2020-045235

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Sub department:
Psychiatry
Role:
Author
ORCID:
0000-0002-2749-1386
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Psychiatry
Role:
Author


Publisher:
BMJ Publishing Group
Journal:
BMJ Open More from this journal
Volume:
10
Issue:
11
Article number:
e045235
Publication date:
2020-11-10
Acceptance date:
2020-09-28
DOI:
ISSN:
2044-6055


Language:
English
Keywords:
Pubs id:
1137572
Local pid:
pubs:1137572
Deposit date:
2020-10-14
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP